As of July 28, 2024, the French health authorities registered close to 39 million confirmed cases of COVID-19 in France. The first cases of the disease were recorded by the end of January 2020, with the highest increase in cases taking place between December 2021 and March 2022.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

This statistic shows the number of confirmed COVID-19 (coronavirus) cases in France as of March 25, 2020, split down by region. On that day (2:00 pm), there were a total of 25,233 cases registered in all of France. With 7,660 cases, the Paris region (Ile-de-France) was the region most touched by the outbreak. The overseas regions registered a total of 313 cases.

SARS-CoV-2 coronavirus

Coronaviruses are a large family of viruses that cause illnesses ranging from a common cold to more severe conditions. But the virus in question here is a new coronavirus which causes a lung disease which has been named COVID-19 (Corona virus disease 2019). It made its first appearance back in December 2019 in the Chinese city of Wuhan. According to Chinese authorities, people infected with the virus could have contracted it by consuming products of animal origin from a large city market, the Huanan Seafood Wholesale Market. On March 11, the World Health Organization classified COVID-19 as a pandemic.

The situation in France

Although the number of confirmed cases is far less important than it is in China, France nevertheless features among the countries most affected by the outbreak. During a survey conducted in mid-March, 35 percent of French people stated being very worried about the spread of this new virus and 49 percent were rather worried. As of March 26, 1,333 people out of 25,600 infected had died from the virus and 3,907 had been listed as cured.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

France recorded 163279 Coronavirus Deaths since the epidemic began, according to the World Health Organization (WHO). In addition, France reported 38989402 Coronavirus Cases. This dataset includes a chart with historical data for France Coronavirus Deaths.

In past 24 hours, France, Europe had N/A new cases, N/A deaths and N/A recoveries.

As of November 24, 2024, France has reported over 39 million coronavirus cases and roughly 168,100 deaths. Like many countries in the world, France has been strongly impacted by the COVID-19 virus.For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Total Covid cases per million people in France, March, 2023 The most recent value is 598987 cases per million as of March 2023, an increase compared to the previous value of 595935 cases per million. Historically, the average for France from February 2020 to March 2023 is 226861 cases per million. The minimum of 1 cases per million was recorded in February 2020, while the maximum of 598987 cases per million was reached in March 2023. | TheGlobalEconomy.com

As of November 24, 2024 there were over 274 million confirmed cases of coronavirus (COVID-19) across the whole of Europe since the first confirmed cases in France in January 2020. France has been the worst affected country in Europe with 39,028,437 confirmed cases, followed by Germany with 38,437,756 cases. Italy and the UK have approximately 26.8 million and 25 million cases respectively. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

Santé Publique France published a daily update on this page indicating the number of confirmed cases of COVID-19 virus infection (“Coronavirus”), region by region, up to and including 25 March 2020.

This dataset offers this data in csv, accumulated over the days.

Before using this data to provide graphic representations or calculations, be sure to read this article.

Confirmed cases of COVID19 contamination by region

The source code used to retrieve and compile data is free license here.

COVID-19, commonly referred to as the Coronavirus, is dominating headlines the world over. The travel & tourism sector is suffering significant disruption and the airlines industry is very much impacted. Air France has not escaped unscathed. Read More

ECDC: COVID-2019: Number of Cases: France data was reported at 11,533.000 Person in 14 Dec 2020. This records a decrease from the previous number of 13,947.000 Person for 13 Dec 2020. ECDC: COVID-2019: Number of Cases: France data is updated daily, averaging 1,384.500 Person from Dec 2019 (Median) to 14 Dec 2020, with 350 observations. The data reached an all-time high of 86,852.000 Person in 08 Nov 2020 and a record low of -766.000 Person in 03 Jun 2020. ECDC: COVID-2019: Number of Cases: France data remains active status in CEIC and is reported by European Centre for Disease Prevention and Control. The data is categorized under High Frequency Database’s Disease Outbreaks – Table ECDC.D001: Coronavirus Disease 2019 (COVID-2019): Cases and Deaths: by EU Member States (Discontinued).

Project Tycho datasets contain case counts for reported disease conditions for countries around the world. The Project Tycho data curation team extracts these case counts from various reputable sources, typically from national or international health authorities, such as the US Centers for Disease Control or the World Health Organization. These original data sources include both open- and restricted-access sources. For restricted-access sources, the Project Tycho team has obtained permission for redistribution from data contributors. All datasets contain case count data that are identical to counts published in the original source and no counts have been modified in any way by the Project Tycho team, except for aggregation of individual case count data into daily counts when that was the best data available for a disease and location. The Project Tycho team has pre-processed datasets by adding new variables, such as standard disease and location identifiers, that improve data interpretability. We also formatted the data into a standard data format. All geographic locations at the country and admin1 level have been represented at the same geographic level as in the data source, provided an ISO code or codes could be identified, unless the data source specifies that the location is listed at an inaccurate geographical level. For more information about decisions made by the curation team, recommended data processing steps, and the data sources used, please see the README that is included in the dataset download ZIP file.

WHO: COVID-2019: Number of Patients: Confirmed: To-Date: France data was reported at 38,997,490.000 Person in 24 Dec 2023. This stayed constant from the previous number of 38,997,490.000 Person for 23 Dec 2023. WHO: COVID-2019: Number of Patients: Confirmed: To-Date: France data is updated daily, averaging 9,850,650.000 Person from Jan 2020 (Median) to 24 Dec 2023, with 1431 observations. The data reached an all-time high of 38,997,490.000 Person in 24 Dec 2023 and a record low of 0.000 Person in 25 Jan 2020. WHO: COVID-2019: Number of Patients: Confirmed: To-Date: France data remains active status in CEIC and is reported by World Health Organization. The data is categorized under High Frequency Database’s Disease Outbreaks – Table WHO.D002: World Health Organization: Coronavirus Disease 2019 (COVID-2019): by Country and Region (Discontinued). In 05 March 2020 report, the figures were reduced from prior situation reports due to separation of territories. Due to some inclusions and exclusions of cases that are not properly reflected in WHO report, which are the result of the retrospective adjustments of national authorities, some current day “To-date” figures will not tally to the sum of previous day “To-date” cases and current day new reported cases. Figures with excluded cases are relatively lower compared to the previous day.

ECDC: COVID-2019: Number of Deaths: France data was reported at 150.000 Person in 14 Dec 2020. This records a decrease from the previous number of 194.000 Person for 13 Dec 2020. ECDC: COVID-2019: Number of Deaths: France data is updated daily, averaging 32.000 Person from Dec 2019 (Median) to 14 Dec 2020, with 350 observations. The data reached an all-time high of 2,004.000 Person in 04 Apr 2020 and a record low of 0.000 Person in 05 Sep 2020. ECDC: COVID-2019: Number of Deaths: France data remains active status in CEIC and is reported by European Centre for Disease Prevention and Control. The data is categorized under High Frequency Database’s Disease Outbreaks – Table ECDC.D001: Coronavirus Disease 2019 (COVID-2019): Cases and Deaths: by EU Member States (Discontinued).

In past 24 hours, French Guiana, South America had N/A new cases, N/A deaths and N/A recoveries.

Full France data by activity (according to the aggregated classification of 88 NAF posts) relating to the carryovers of contributions of employers affiliated to the general scheme in the context of the COVID-19 health crisis (dues from 15 March to 15 December 2020). Situations at the end of March to December 2020.

In order to take into account the impact of the coronavirus outbreak on economic activity, the Urssaf network triggered exceptional measures to support companies with serious cash flow difficulties as of the deadline of 15 March. In the event of major difficulties, companies could postpone, first without prior request and then on request, all or part of the payment of employee and employer contributions.

This dataset describes all the amounts carried over, regardless of whether they are part of a mechanism allowing the carry-over or not. The amounts of carry-overs therefore correspond to the “rests to be recovered”.

The data are declined by payment deadline: the 5th or 15th of the month. Contributions must in principle be paid during the month following the period of paid employment:

• no later than the 5th of that month for employers with at least 50 employees whose pay is paid in the same month as the period of work;

• no later than the 15th of this month in other cases.

Source: ACOSS-Urssaf, extraction early May 2021

Indicators:

• Number of institutions at maturity (*)
• Amount of contributions due
• Number of establishments that have carried over (*)
• Amount of carryovers

(*) WARNING: information on the number of establishments should be interpreted with caution. Indeed, as institutions are counted at each maturity, the selection of a period covering more than one month leads to the same institutions being counted several times (an institution is likely to report each month). Thus, in order to have the total number of institutions without double accounts, it is necessary to select two maturities of the same month.

Methodological clarifications:

• these data take into account the social contribution exemption and payment aid schemes introduced by Article 65 of Law No 2020-935 of 30 July 2020 to support the companies most affected by the crisis. The contributions due are indeed amounts after application of the exemptions. And carry-overs are amounts after the payment aid has been charged, which reduces the amounts to be paid by the undertakings concerned.
• an institution is counted as deferred if the amount of contributions not paid at maturity exceeds EUR 44
• the sector of activity “nca not elsewhere” includes the agricultural sector (AZ) for the general scheme (most of the AZ sector falls under the agricultural scheme, out of field here), extraterritorial activities (UZ) and unknown activities.

DATAVIZ: putting in perspective

Actions of Public Health France Public Health France’s mission is to improve and protect the health of populations. During the health crisis linked to the COVID-19 outbreak, Santé publique France is responsible for monitoring and understanding the dynamics of the epidemic, anticipating the various scenarios and putting in place actions to prevent and limit the transmission of this virus on national territory. ### The Tracking Information System (SI-DEP) The new screening information system (SI-DEP), which has been in operation since 13 May 2020, is a secure platform where the results of the laboratory tests carried out by all city and hospital laboratories for SARS-COV2 are systematically recorded. The creation of this information system is authorised for a period of 6 months from the end of the state of health emergency by application of Decree No 2020-551 of 12 May 2020 on the information systems referred to in Article 11 of Law No 2020-546 of 11 May 2020 extending the state of health emergency and supplementing its provisions. ### Description of data This dataset provides information at the departmental and regional level: — the daily and weekly incidence rate per age group; — the daily and weekly standardised incidence rate; — the sliding standardised incidence rate. This dataset provides information at the national level: — the daily and weekly incidence rate by age group and sex; — the daily and weekly standardised incidence rate; — the sliding standardised incidence rate. The incidence rate corresponds to the number of positive tests per 100,000 inhabitants. It shall be calculated as follows: (100000 * number of positive cases)/Population Accuracy: — From 29/08 onwards, laboratory data indicators (SI-DEP) show rates of incidence, positivity and screening adjusted for screenings conducted at airports upon arrival of international flights. — For more information, see the methodological note available in the resources. Limits: — Only the biological tests of persons for whom the residence department could be located are shown on the maps. Persons whose department could not be traced in the SIDEP data are counted only at the whole French level. As a result, the sum of the tests indicated in the departments or regions is less than the number of tests indicated in France. — The time limit for repeating tests may exceed 9 days in some cases. The indicators are adjusted daily according to the receipt of the results. ### Notable changes Since 8 December, after verifying the quality of the reported data, all results of RT-PCR or Antigenic tests have been included in the production of national and territorial epidemiological indicators (incidence rates, positivity rates and screening rates) relevant to the monitoring of the COVID-19 outbreak. On the other hand, the epidemic is prolonging in time and screening capacities have increased, leading to an increasing frequency of people tested several times. Thus, an adjustment of the methods of splitting for patients benefiting from repeated tests and therefore the definition of the persons tested was necessary. Public Health France, in its patient-centred epidemiological approach, has therefore adapted its methods to ensure that these indicators reflect, in particular, the proportion of infected people among the population tested. These developments have no impact on the trends and interpretation of the dynamics of the epidemic, which remain the same. More precise test data (impact and positivity) are also published by Santé publique France (SI-DEP data).

An evaluation was conducted to predict the economic and clinical burden of vaccinating all immunocompromised (IC) individuals aged ≥30 years with mRNA-1273 variant-adapted COVID-19 vaccines versus BNT162b2 variant-adapted vaccines in Fall 2023 and Spring 2024 in France. The number of symptomatic SARS-CoV-2 infections, hospitalizations or deaths due to COVID-19, and long COVID cases, costs and quality-adjusted life years (QALYs) were estimated using a static decision-analytic model. Predicted vaccine effectiveness (VE) were based on real-world data from the original and BA.4/5 variant-adapted vaccines, suggesting higher protection against infection and hospitalization with mRNA-1273 vaccines. VE estimates were combined with COVID-19 incidence and probability of COVID-19 severe outcomes. Uncertainty surrounding VE, vaccine coverage, infection incidence, hospitalization and mortality rates, costs and QALYs were evaluated in sensitivity analyses. In an ideal situation where 100% coverage is achieved, the mRNA-1273 variant-adapted vaccine is predicted to prevent an additional 3,882 infections, 357 hospitalizations, 81 deaths, and 326 long COVID cases when compared to BNT162b2 variant-adapted vaccines in 230,000 IC individuals. This translates to €10.1 million cost-savings from a societal perspective and 645 QALYs gained. Results were consistent across all analyses and most sensitive to variations surrounding VE and coverage. These findings highlight the importance of increasing vaccine coverage, and ability to induce higher levels of protection with mRNA-1273 formulations in this vulnerable population.

This graph reveals the number of COVID-19 coronavirus cases investigated in France between February 24 and March 15, 2020, according to the result. Out of a total of 36,747 tests carried out during this period, 6,153 turned out positive.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Analysis of ‘COVID-19 in Turkey’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://www.kaggle.com/gkhan496/covid19-in-turkey on 28 January 2022.

--- Dataset description provided by original source is as follows ---

Context

COVID-19 data in Turkey. Daily Covid-19 data published by our health ministry.

Content

time_series_covid_19_confirmed_tr
time_series_covid_19_recovered_tr
time_series_covid_19_deaths_tr
time_series_covid_19_intubated_tr
time_series_covid_19_intensive_care_tr.csv 
time_series_covid_19_tested_tr.csv 
test_numbers : Number of test (daily)

Total data

covid_19_data_tr

Github

Github repo : https://github.com/gkhan496/Covid19-in-Turkey/

Acknowledgements

We would like to thank our health ministry and all health workers.

Country level datasets

USA - https://www.kaggle.com/sudalairajkumar/covid19-in-usa Indonesia - https://www.kaggle.com/ardisragen/indonesia-coronavirus-cases France - https://www.kaggle.com/lperez/coronavirus-france-dataset Tunisia - https://www.kaggle.com/ghassen1302/coronavirus-tunisia Japan - https://www.kaggle.com/tsubasatwi/close-contact-status-of-corona-in-japan South Korea - https://www.kaggle.com/kimjihoo/coronavirusdataset Italy - https://www.kaggle.com/sudalairajkumar/covid19-in-italy Brazil - https://www.kaggle.com/unanimad/corona-virus-brazil

https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F2311214%2Feaf61a1cf97850b64aefd52d3de5890b%2FXMhaJ.png?generation=1586182028591623&alt=media" alt="">

Source : https://fastlifehacks.com/n95-vs-ffp/

https://covid19.saglik.gov.tr https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html?fbclid=IwAR0k49fzqTxI4HBBZF7n4hLX4Zj0Q2KII_WOEo7agklC20KODB3TOeF8RrU#/bda7594740fd40299423467b48e9ecf6 http://who.int/ --situation reports https://evrimagaci.org/covid19#turkey-statistics

--- Original source retains full ownership of the source dataset ---

Project Tycho datasets contain case counts for reported disease conditions for countries around the world. The Project Tycho data curation team extracts these case counts from various reputable sources, typically from national or international health authorities, such as the US Centers for Disease Control or the World Health Organization. These original data sources include both open- and restricted-access sources. For restricted-access sources, the Project Tycho team has obtained permission for redistribution from data contributors. All datasets contain case count data that are identical to counts published in the original source and no counts have been modified in any way by the Project Tycho team, except for aggregation of individual case count data into daily counts when that was the best data available for a disease and location. The Project Tycho team has pre-processed datasets by adding new variables, such as standard disease and location identifiers, that improve data interpretability. We also formatted the data into a standard data format. All geographic locations at the country and admin1 level have been represented at the same geographic level as in the data source, provided an ISO code or codes could be identified, unless the data source specifies that the location is listed at an inaccurate geographical level. For more information about decisions made by the curation team, recommended data processing steps, and the data sources used, please see the README that is included in the dataset download ZIP file.